Perceptive Advisors TMCI Position
ExitedPerceptive Advisors exited their position in TREACE MEDICAL CONCEPTS, INC. (TMCI) in Q2 2024, after holding the stock for 6 quarters.
The position was first reported in Q1 2023 and has been tracked across 6 quarterly 13F filings.
1 other tracked fund also holds TMCI.
About TREACE MEDICAL CONCEPTS, INC.
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Full company profile →Short Interest
8.1%
4.0 days to cover
Perceptive Advisors TMCI Position History
Frequently Asked Questions
Does Perceptive Advisors own TMCI?
No. Perceptive Advisors exited their position in TREACE MEDICAL CONCEPTS, INC. (TMCI) in Q2 2024. They previously held the stock for 6 quarters.
How many hedge funds own TMCI?
1 specialist biotech hedge fund currently holds TMCI, including Driehaus Capital. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy TMCI?
Perceptive Advisors's position in TMCI was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's TMCI position increasing or decreasing?
Perceptive Advisors completely exited their TMCI position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
TMCICompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →